aid: georgiamune
name: Georgiamune
description: >-
  Georgiamune Inc. is a Gaithersburg, Maryland based biopharmaceutical company
  developing first-in-class immunotherapies that reprogram immune signaling
  pathways to rebalance the immune system and restore health across cancer and
  autoimmune diseases. Built on a target-discovery platform, its pipeline of
  immunomodulators spans clinical, preclinical, and discovery stages, including
  the clinical-stage dual-functioning antibody GIM-122, the regulatory T-cell
  (Treg) inhibitor GIM-531, and the Treg activator GIM-407, alongside additional
  antibody and small-molecule programs. The company was surfaced as a
  venture-backed portfolio company and profiled in the API Evangelist network;
  it does not currently publish a public API, developer portal, or programmatic
  interface.
url: https://raw.githubusercontent.com/api-evangelist/georgiamune/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- general-catalyst
x-tier: stub
x-tier-reason: portfolio-lead
x-api-surface: none
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-19'
image: https://georgiamune.com/favicon.ico
tags:
- Company
- Biopharmaceutical
- Immunotherapy
- Oncology
- Autoimmune
- Drug Discovery
- Biotechnology
- Immunology
apis: []
common:
- type: Website
  url: https://georgiamune.com
- type: Blog
  url: https://georgiamune.com/news
- type: DomainSecurity
  url: security/georgiamune-domain-security.yml
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence